Given their distribution in normal breast, we assessed the expression of CAV1 and CAV2 in a large population of invasive breast cancer to determine whether they would be preferentially expressed in the subgroup of breast carcinomas with myoepithelial/basal-like phenotype and their prognostic implications in breast cancer. The gene discussed is CAV2; the disease is breast carcinoma.